IBIO – iBio Inc
iBio, Inc.IBIO
$0.7675Name : iBio, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,678,562.00
EPSttm : -0.04
iBio, Inc.
$0.7675
4.06%$0.0325Float Short %
11.12
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.29
EPS Last/This Y
4.73
EPS This/Next Y
0.58
Price
0.8
Target Price
4.87
Analyst Recom
1
Performance Q
-74.76
Relative Volume
0.33
Beta
1
Ticker: IBIO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | IBIO | 1.175 | N/A | N/A | 0 |
| 2025-04-15 | IBIO | 1.09 | N/A | N/A | 0 |
| 2025-04-16 | IBIO | 0.9615 | N/A | N/A | 0 |
| 2025-04-17 | IBIO | 0.89 | N/A | N/A | 0 |
| 2025-04-18 | IBIO | 0.8899 | N/A | N/A | 0 |
| 2025-04-21 | IBIO | 0.8602 | N/A | N/A | 0 |
| 2025-04-22 | IBIO | 0.7 | N/A | N/A | 0 |
| 2025-04-23 | IBIO | 0.7512 | N/A | N/A | 0 |
| 2025-04-24 | IBIO | 0.8256 | N/A | N/A | 0 |
| 2025-04-25 | IBIO | 0.919 | N/A | N/A | N/A |
| 2025-04-28 | IBIO | 1.05 | N/A | N/A | N/A |
| 2025-04-29 | IBIO | 1.04 | N/A | N/A | 0 |
| 2025-04-30 | IBIO | 1.06 | N/A | N/A | 0 |
| 2025-05-01 | IBIO | 1.02 | N/A | N/A | 0 |
| 2025-05-02 | IBIO | 0.9937 | N/A | N/A | 0 |
| 2025-05-05 | IBIO | 0.975 | N/A | N/A | 0 |
| 2025-05-06 | IBIO | 0.8406 | N/A | N/A | 0 |
| 2025-05-07 | IBIO | 0.847 | N/A | N/A | 0 |
| 2025-05-08 | IBIO | 0.8295 | N/A | N/A | 0 |
| 2025-05-09 | IBIO | 0.7708 | N/A | N/A | 0 |
| 2025-05-12 | IBIO | 0.79 | N/A | N/A | 0 |
| 2025-05-13 | IBIO | 0.8 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | IBIO | 1.18 | 67.3 | - | -1.59 |
| 2025-04-15 | IBIO | 1.10 | 67.3 | - | -1.59 |
| 2025-04-16 | IBIO | 0.97 | 67.3 | - | -1.59 |
| 2025-04-17 | IBIO | 0.89 | 67.3 | - | -1.59 |
| 2025-04-18 | IBIO | 0.89 | 67.3 | - | -1.59 |
| 2025-04-21 | IBIO | 0.85 | 67.3 | - | -1.59 |
| 2025-04-22 | IBIO | 0.70 | 67.3 | - | -1.59 |
| 2025-04-23 | IBIO | 0.76 | 67.3 | - | -1.59 |
| 2025-04-24 | IBIO | 0.85 | 67.3 | - | -1.59 |
| 2025-04-25 | IBIO | 0.92 | 67.3 | - | -1.59 |
| 2025-04-28 | IBIO | 1.05 | 67.3 | - | -1.59 |
| 2025-04-29 | IBIO | 1.05 | 67.3 | - | -1.59 |
| 2025-04-30 | IBIO | 1.06 | 67.3 | - | -1.59 |
| 2025-05-01 | IBIO | 1.03 | 67.3 | - | -1.59 |
| 2025-05-02 | IBIO | 1.01 | 67.3 | - | -1.59 |
| 2025-05-05 | IBIO | 0.97 | 53.9 | - | -1.59 |
| 2025-05-06 | IBIO | 0.83 | 53.9 | - | -1.59 |
| 2025-05-07 | IBIO | 0.85 | 53.9 | - | -1.59 |
| 2025-05-08 | IBIO | 0.83 | 53.9 | - | -1.59 |
| 2025-05-09 | IBIO | 0.77 | 53.9 | - | -1.77 |
| 2025-05-12 | IBIO | 0.79 | 53.9 | - | -1.77 |
| 2025-05-13 | IBIO | 0.80 | 53.9 | - | -1.77 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | IBIO | 75.53 | 2.89 | 12.59 |
| 2025-04-15 | IBIO | 75.53 | 2.89 | 12.59 |
| 2025-04-16 | IBIO | 75.49 | 2.89 | 12.59 |
| 2025-04-17 | IBIO | 75.49 | 2.89 | 12.59 |
| 2025-04-18 | IBIO | 75.42 | 2.89 | 12.59 |
| 2025-04-21 | IBIO | 75.43 | 2.89 | 12.59 |
| 2025-04-22 | IBIO | 75.43 | 2.89 | 12.59 |
| 2025-04-23 | IBIO | 75.50 | 2.89 | 12.59 |
| 2025-04-24 | IBIO | 75.51 | 2.89 | 12.59 |
| 2025-04-25 | IBIO | 75.49 | 2.89 | 12.59 |
| 2025-04-28 | IBIO | 75.54 | 2.89 | 9.94 |
| 2025-04-29 | IBIO | 75.54 | 2.89 | 9.94 |
| 2025-04-30 | IBIO | 75.45 | 2.89 | 9.94 |
| 2025-05-01 | IBIO | 75.45 | 2.89 | 9.94 |
| 2025-05-02 | IBIO | 75.43 | 2.89 | 9.94 |
| 2025-05-05 | IBIO | 75.53 | 1.66 | 9.94 |
| 2025-05-06 | IBIO | 75.53 | 1.66 | 9.94 |
| 2025-05-07 | IBIO | 34.61 | 1.66 | 5.94 |
| 2025-05-08 | IBIO | 34.61 | 1.66 | 5.94 |
| 2025-05-09 | IBIO | 34.60 | 1.66 | 5.94 |
| 2025-05-12 | IBIO | 34.60 | 4.48 | 11.12 |
| 2025-05-13 | IBIO | 34.60 | 4.48 | 11.12 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.49
Avg. EPS Est. Current Quarter
-0.34
Avg. EPS Est. Next Quarter
-0.2
Insider Transactions
34.6
Institutional Transactions
4.48
Beta
1
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
32
Sentiment Score
19
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
4.87
P/E
Forward P/E
PEG
P/S
34.77
P/B
0.71
P/Free Cash Flow
EPS
-2.33
Average EPS Est. Cur. Y
-1.77
EPS Next Y. (Est.)
-1.19
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-5597.87
Relative Volume
0.33
Return on Equity vs Sector %
-208.1
Return on Equity vs Industry %
-191.2
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.18
EBIT Estimation
iBio, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 16
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
stock quote shares IBIO – iBio Inc Stock Price stock today
news today IBIO – iBio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch IBIO – iBio Inc yahoo finance google finance
stock history IBIO – iBio Inc invest stock market
stock prices IBIO premarket after hours
ticker IBIO fair value insiders trading